MedTrace Logo

Long Term Study of 3 Radiofrequency Devices

NCT04720027 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2022-08-15

No results posted yet for this study

Summary

To establish which of the radiofrequency venous ablation modalities studied in the original 3RF study (Venefit (Closurefast), vs. Radiofrequency induced Thermal Therapy vs. Endovenous Radiofrequency) is most effective in relieving patients' symptoms and signs from varicose veins disease, and in maintaining absence of reflux in the treated vein segment (of the great saphenous vein (GSV)) 5 years following surgery.

Conditions

  • Varicose Veins of Lower Limb

Interventions

DIAGNOSTIC_TEST

Duplex imaging

Completion of AVVQ and EQ5D questionnairs

Sponsors & Collaborators

  • Worcestershire Acute Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Isaac Nyamekye, FRCS, MD · Worcestershire Acute Hospitals NHS Trust

Eligibility

Min Age
23 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2022-03-31
Completion
2022-06-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720027 on ClinicalTrials.gov